tradingkey.logo

Insulet Corp

PODD
289.620USD
-3.260-1.11%
收盘 12/19, 16:00美东报价延迟15分钟
20.37B总市值
82.66市盈率 TTM

Insulet Corp

289.620
-3.260-1.11%

关于 Insulet Corp 公司

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Insulet Corp简介

公司代码PODD
公司名称Insulet Corp
上市日期May 15, 2007
CEOMcevoy (Ashley)
员工数量3900
证券类型Ordinary Share
年结日May 15
公司地址100 Nagog Park
城市ACTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编01720-3440
电话19786007000
网址https://www.omnipod.com
公司代码PODD
上市日期May 15, 2007
CEOMcevoy (Ashley)

Insulet Corp公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+2.89%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-8.50%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-28.94%
Ms. Ashley Mcevoy
Ms. Ashley Mcevoy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
9.54K
+238500.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+17.43%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+17.01%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
3.85K
+33.25%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
3.58K
--
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.56K
-16.16%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
3.09K
-13.48%
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+2.89%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-8.50%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-28.94%
Ms. Ashley Mcevoy
Ms. Ashley Mcevoy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
9.54K
+238500.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+17.43%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+17.01%

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
业务USD
名称
营收
占比
U.S.Omnipod
453.20M
69.82%
International Omnipod
185.80M
28.62%
Drug Delivery
10.20M
1.57%
地区USD
名称
营收
占比
United States
463.30M
71.38%
All Other
185.80M
28.62%
业务
地区
业务USD
名称
营收
占比
U.S.Omnipod
453.20M
69.82%
International Omnipod
185.80M
28.62%
Drug Delivery
10.20M
1.57%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.46%
Fidelity Management & Research Company LLC
9.83%
Capital Research Global Investors
6.47%
BlackRock Institutional Trust Company, N.A.
6.29%
State Street Investment Management (US)
4.39%
其他
60.56%
持股股东
持股股东
占比
The Vanguard Group, Inc.
12.46%
Fidelity Management & Research Company LLC
9.83%
Capital Research Global Investors
6.47%
BlackRock Institutional Trust Company, N.A.
6.29%
State Street Investment Management (US)
4.39%
其他
60.56%
股东类型
持股股东
占比
Investment Advisor
64.92%
Investment Advisor/Hedge Fund
23.48%
Hedge Fund
4.88%
Pension Fund
2.61%
Research Firm
2.52%
Sovereign Wealth Fund
1.57%
Bank and Trust
1.22%
Individual Investor
0.30%
Family Office
0.05%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1546
72.07M
102.39%
-3.66M
2025Q2
1541
72.80M
103.47%
-3.81M
2025Q1
1569
72.82M
103.50%
-3.52M
2024Q4
1508
72.57M
103.34%
-4.94M
2024Q3
1436
73.14M
104.31%
-3.15M
2024Q2
1408
72.17M
103.04%
-3.02M
2024Q1
1350
71.60M
102.26%
-3.12M
2023Q4
1320
72.91M
104.42%
-1.52M
2023Q3
1254
72.05M
103.19%
-4.06M
2023Q2
1223
73.42M
105.35%
-3.44M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
The Vanguard Group, Inc.
8.68M
12.33%
+38.89K
+0.45%
Jun 30, 2025
Fidelity Management & Research Company LLC
6.86M
9.74%
-271.19K
-3.80%
Jun 30, 2025
Capital Research Global Investors
4.74M
6.73%
-1.34M
-22.06%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
4.35M
6.18%
-13.40K
-0.31%
Jun 30, 2025
State Street Investment Management (US)
3.06M
4.34%
+32.74K
+1.08%
Jun 30, 2025
Baillie Gifford & Co.
2.14M
3.03%
-115.69K
-5.14%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.93M
2.74%
+58.31K
+3.12%
Jun 30, 2025
ClearBridge Investments, LLC
1.54M
2.18%
+56.63K
+3.83%
Jun 30, 2025
American Century Investment Management, Inc.
1.31M
1.86%
+157.07K
+13.63%
Jun 30, 2025
Fidelity International
1.13M
1.61%
-155.38K
-12.09%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Langar Global HealthTech ETF
7.26%
Innovator IBD Breakout Opportunities ETF
4.88%
Global X HealthTech ETF
4.76%
Goldman Sachs Future Health Care Equity ETF
4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.7%
iShares Health Innovation Active ETF
3%
Congress SMid Growth ETF
2.82%
iShares U.S. Medical Devices ETF
2.62%
FT Raymond James Multicap Growth Equity ETF
2.3%
Acruence Active Hedge US Equity ETF
2.27%
查看更多
Langar Global HealthTech ETF
占比7.26%
Innovator IBD Breakout Opportunities ETF
占比4.88%
Global X HealthTech ETF
占比4.76%
Goldman Sachs Future Health Care Equity ETF
占比4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
占比3.7%
iShares Health Innovation Active ETF
占比3%
Congress SMid Growth ETF
占比2.82%
iShares U.S. Medical Devices ETF
占比2.62%
FT Raymond James Multicap Growth Equity ETF
占比2.3%
Acruence Active Hedge US Equity ETF
占比2.27%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Insulet Corp的前五大股东是谁?

Insulet Corp 的前五大股东如下:
The Vanguard Group, Inc.持有股份:8.68M,占总股份比例:12.33%。
Fidelity Management & Research Company LLC持有股份:6.86M,占总股份比例:9.74%。
Capital Research Global Investors持有股份:4.74M,占总股份比例:6.73%。
BlackRock Institutional Trust Company, N.A.持有股份:4.35M,占总股份比例:6.18%。
State Street Investment Management (US)持有股份:3.06M,占总股份比例:4.34%。

Insulet Corp的前三大股东类型是什么?

Insulet Corp 的前三大股东类型分别是:
The Vanguard Group, Inc.
Fidelity Management & Research Company LLC
Capital Research Global Investors

有多少机构持有Insulet Corp(PODD)的股份?

截至2025Q3,共有1546家机构持有Insulet Corp的股份,合计持有的股份价值约为72.07M,占公司总股份的102.39%。与2025Q2相比,机构持股有所增加,增幅为-1.08%。

哪个业务部门对Insulet Corp的收入贡献最大?

在FY2025Q2,U.S.Omnipod业务部门对Insulet Corp的收入贡献最大,创收453.20M,占总收入的69.82%。
KeyAI